- Tech & Product DD
- E-Health & MedTech
Code & Co. advises capiton as it acquires a majority stake in Wundex
Code & Co. provides Tech & Product DD to capiton on its acquisition of a leading provider of wound care services in Germany.
- Backed by an integrated digital platform, Wundex’s qualified wound managers provide home care services that enable faster and more effective wound treatment.
- Wundex significantly reduces the workload of general care providers and physicians.
- capiton has reserved additional funds to finance both organic and inorganic growth initiatives.
- Code & Co. led Tech & Product DD for the investor.
Headquartered in Senden, Germany, Wundex offers a complete range of 60,000 home care products and decubitus systems. With its three business units, home care services, home care products and decubitus systems, Wundex has built a fully integrated unique home care offering. The company‘s qualified wound managers provide home care services that enable faster and more effective wound treatment for patients with chronic wounds.
Berlin-headquartered private equity investor capiton acquired a majority stake in Wundex. The investor and management plan to grow the Wundex business organically as well as through acquisitions in the fragmented market.
Code & Co. advised capiton with regard to Wundex’s tech-enabled services. In an effort to drastically scale its operations, Wundex plans to further expand and integrate its existing tech solutions, including app, e-commerce capabilities, and HealthTech-focused web platforms.
This audit is the latest example of why clients across Europe rely on Code & Co. as an established technology and product advisor when it comes to tech acquisitions.
Code & Co. is an independent advisory firm specialized in advising funds in the global alternative investment industry. Our expertise is modern and holistic technology and product due diligence. From outside-in audits and confirmatory due diligence to portfolio audits, exit preparation, and vendor due diligence, we provide our clients with crucial insight across the entire investment life cycle.